Related Experiment Video

Updated: Jun 9, 2026

Ocular Therapeutic Delivery and Advanced Tissue Retrieval in Adult Rats
06:30

Ocular Therapeutic Delivery and Advanced Tissue Retrieval in Adult Rats

Published on: May 23, 2025

The orbital fibroblast: a key player and target for therapy in graves' ophthalmopathy

Leendert van Steensel1, Willem A Dik

  • 1Department of Immunology, Erasmus MC, Rotterdam, the Netherlands.

Orbit (Amsterdam, Netherlands)
|September 4, 2010
PubMed

Insights

Orbital fibroblasts are key drivers of Graves' ophthalmopathy (GO). Targeting the PDGF system in these fibroblasts offers a promising therapeutic strategy for GO treatment.

Area of Science:

  • Ophthalmology
  • Endocrinology
  • Immunology

Background:

  • Graves' ophthalmopathy (GO) is an autoimmune condition affecting the eye socket.
  • Orbital fibroblasts are implicated in the inflammatory and fibrotic processes of GO.

Purpose of the Study:

  • To elucidate the role of orbital fibroblasts in GO pathogenesis.
  • To highlight the significance of Platelet-Derived Growth Factor-BB (PDGF-BB) in this context.
  • To identify potential therapeutic targets for GO.

Main Methods:

  • Review of existing literature on orbital fibroblast function in GO.
  • Analysis of the role of PDGF-BB signaling pathways.
  • Discussion of therapeutic implications.

Main Results:

  • Orbital fibroblasts significantly contribute to GO development through various mechanisms.
  • PDGF-BB plays a crucial role in mediating the actions of orbital fibroblasts in GO.
  • The PDGF system acting on orbital fibroblasts emerges as a key factor.

Conclusions:

  • Orbital fibroblasts are central to GO pathogenesis.
  • Targeting the PDGF system in orbital fibroblasts presents a viable therapeutic strategy for GO.

More Related Videos

Clinical Application of Intense Pulsed Light Therapy and Radio Frequency for Treatment of Ocular Surface Diseases07:36

Clinical Application of Intense Pulsed Light Therapy and Radio Frequency for Treatment of Ocular Surface Diseases

Published on: July 3, 2025

Related Concept Videos

Introduction to Fibroblasts01:09

Introduction to Fibroblasts

Rudolph Virchow discovered spindle-shaped cells called fibroblasts in 1858. Inactive fibroblasts, called fibrocytes, become activated by various stimuli, such as growth factors and inflammatory cytokines. Activated fibroblasts play a crucial role in wound healing, inflammation, formation of new blood vessels, and cancer progression. Uncontrolled activation of fibroblasts results in fibrosis, the excess deposition of fibrous tissue, which can lead to scarring and affect normal organs. This...
Graves Disease II: Pathophysiology01:24

Graves Disease II: Pathophysiology

Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
Graves' Disease I: Introduction01:28

Graves' Disease I: Introduction

Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...
Glaucoma: Overview01:25

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...